✦ LIBER ✦

Corona stenting in a patient menorrhagia: use of a gonadotrophin releasing hormone agonist to facilitate anticoagulation

✍ Scribed by Charanjit Khurana; Peter Taylor; Mark A de Belder

Book ID: 117355286
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 35 KB
Volume: 63
Category: Article
ISSN: 0167-5273
DOI: 10.1016/s0167-5273(97)00272-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of a super active luteinizing hormon

Use of a super active luteinizing hormone releasing hormone (LHRH) agonist in the treatment of menorrhagia

✍ ROBERT W. SHAW; HAMISH M. ERASER 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 236 KB

AN ATTEMPT TO ALTER THE PATHOPHYSIOLOGY

AN ATTEMPT TO ALTER THE PATHOPHYSIOLOGY OF POLYCYSTIC OVARY SYNDROME USING A GONADOTROPHIN HORMONE RELEASING HORMONE AGONIST—NAFARELIN

✍ IOLA A. WILLIAMS; ROBERT W. SHAW; GRAHAM BURFORD 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 508 KB

Short Communications: Ovarian Hyperstimu

Short Communications: Ovarian Hyperstimulation After the Sole Use of a Gonadotrophin-Releasing Hormone Agonist (Nafarelin) as a Complication of In Vitro Fertilisation Treatment

✍ S. Brett; P. Y. K. Yong; K. J. Thong 📂 Article 📅 2001 🏛 Springer US 🌐 English ⚖ 45 KB

Gonadotrophin and gonadal steroid respon

Gonadotrophin and gonadal steroid response to a single dose of a long-acting agonist of gonadotrophin-releasing hormone in ovulatory and anovulatory women with polycystic ovary syndrome

✍ Davinia White; Amanda Leigh; Catherine Wilson; Amanda Donaldson; Stephen Franks 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 578 KB

THE USE OF LUTEINIZING HORMONE RELEASING

THE USE OF LUTEINIZING HORMONE RELEASING HORMONE AGONISTS ADMINISTRATED TO PATIENTS WITH PROSTATE CANCER PREDISPOSES TO DEMENTIA: A POPULATION-BASED ANALYSIS

✍ Capitanio, Umberto; Isbarn, Hendrik; Jeldres, Claudio; Gallina, Andrea; Gagne, S 📂 Article 📅 2009 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 49 KB

Use of gonadotropin releasing hormone an

Use of gonadotropin releasing hormone antagonist (GnRHAnt) to reduce ovarian hyperstimulation syndrome (OHSS) in IVF patients on a gonadotropin releasing hormone agonist (GnRHa) suppression protocol

✍ L.N. Weckstein; D.S. Wachs; M. Hinckley; S. Willman; C. Sgarlata; D. Galen 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 44 KB